On November 7, 2018, NASDAQ displayed on their billboard in New York Times Square the news of the FDA approval of Amphastar's Primatene® MIST.

 

Copyright © 2022 Amphastar Pharmaceuticals, Inc.

Privacy      Terms & Conditions

This site is intended for residents of the United States